Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
As of April 2025 Biogen has a market cap of ยฃ13.14 Billion. This makes Biogen the world's 1073th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | ยฃ13.14 B | -25.16% |
2024 | ยฃ17.56 B | -40.3% |
2023 | ยฃ29.43 B | -10.71% |
2022 | ยฃ32.96 B | 26.25% |
2021 | ยฃ26.10 B | -5.55% |
2020 | ยฃ27.64 B | -29.87% |
2019 | ยฃ39.41 B | -15.68% |
2018 | ยฃ46.74 B | -6.22% |
2017 | ยฃ49.84 B | -0.31% |
2016 | ยฃ50.00 B | 10.65% |
2015 | ยฃ45.19 B | -11.64% |
2014 | ยฃ51.14 B | 27.68% |
2013 | ยฃ40.05 B | 86.96% |
2012 | ยฃ21.42 B | 24.57% |
2011 | ยฃ17.19 B | 64.63% |
2010 | ยฃ10.44 B | 14.97% |
2009 | ยฃ9.08 B | -2.93% |
2008 | ยฃ9.36 B | 10.49% |
2007 | ยฃ8.47 B | 0.07% |
2006 | ยฃ8.46 B | -5% |
2005 | ยฃ8.91 B | -24.4% |
2004 | ยฃ11.78 B |
On Apr 24th, 2025 the market cap of Biogen was reported to be: